Dr. Keith Roach discusses why some patients thrive on lower Zepbound doses and if you need a Shingrix booster.
A rare condition causing sudden, painless blindness in one eye may be doubled among people taking popular GLP-1 drugs for ...
Dylan Dreyer got called out for a comment she directed toward fellow co-anchor Craig Melvin during the Thursday, Sept. 24, broadcast of the talk show.
The FDA has warned a major compounding pharmacy that it violated federal law by making copies of blockbuster weight-loss drugs in "inordinate amounts." ...
A new study identified more than 1 million people taking weight-loss drugs without any apparent medical reason to do so.
News Nation on MSN
New therapy could stop GLP-1-related muscle loss: Study
The therapy blocks a gene called ZFP423.
Today's Dylan Dreyer and Craig Melvin got into a hilarious on-air exchange after Dreyer asked Melvin if he’s taking any ...
 Remedy Meds  also stood out as an excellent choice in 2026. It combines affordable, doctor-guided care with an ...
Approximately one in eight U.S. adults is currently taking a GLP-1 drug. Usage is reshaping one of the country's biggest ...
Children taking GLP-1 medications (such as Victoza, Saxenda, Trulicity, and Ozempic) for weight loss, prediabetes, or type 2 ...
For years, the price tag has been one of the biggest barriers to GLP-1 medications like Ozempic and Wegovy. That is starting ...
Recent research now shows that a sizable number of Americans have been taking GLP-1s off-label. Scientists at New York University and others examined the medical records of Americans across the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results